Earlier this month at the annual J.P. Morgan conference, the biotech industry launched its encore to a wildly successful 2020 – virtually.  And, as is becoming the common scenario, attendees found both pros and cons to our new (temporary?) reality. “J.P. Morgan and the meetings around J.P. Morgan are such a fun week for us in […]

The “Woogies” at Wugen have been busy these past three years. BioSpace sat down with CEO John McKearn, Ph.D. to find up what his company has been up to. McKearn told BioSpace that Wugen started as a twinkle in his eye when he was scouting out some technology at Washington University (WU) in St. Louis. […]

Dr. Javitt has played leadership roles in seven successful healthcare IT and biopharma startups with public exits. He has additionally led drug-development engagements for Merck, Allergan, Pharmacia, Novartis, and Pfizer. He was appointed to healthcare leadership roles under Presidents Reagan, George H.W. Bush, Clinton, and George W. Bush. In the latter role he was commissioned […]